A high affinity interaction of plasminogen with fibrin is not essential for efficient activation by tissue-type plasminogen activator

Journal of Biological Chemistry

Volumn 287, Issue 7, 2012, Pages 4652-4661

  Kim, Paul Y ^a   Tieu, Long D ^a   Stafford, Alan R ^a   Fredenburgh, James C ^a   Weitz, Jeffrey I ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CATALYTIC EFFICIENCIES; COFACTOR ACTIVITY; CRYPTIC SITES; HIGH AFFINITY; HIGH AFFINITY BINDING; TISSUE-TYPE PLASMINOGEN ACTIVATOR;

TISSUE;

SURFACE PLASMON RESONANCE;

FIBRIN; PLASMINOGEN; TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BINDING AFFINITY; BINDING KINETICS; CATALYSIS; COMPLEX FORMATION; CONTROLLED STUDY; KRINGLE DOMAIN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; SURFACE PLASMON RESONANCE;

ENZYME ACTIVATION; ENZYME STABILITY; FIBRIN; HUMANS; KRINGLES; PLASMINOGEN; PROTEIN BINDING; SURFACE PLASMON RESONANCE; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84856884891     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.317719     Document Type: Article

References (33)

1. Lijnen, H. R., and Collen, D. (1995) Hematology. Basic Principles and Practice, Churchill Livingstone, New York
2. Bachmann, F. (1994) Hemostasis and Thrombosis: Basic Principles and Clinical Practice, J. B. Lipincott Co., Philadelphia, PA
3. Fredenburgh, J. C., and Nesheim, M. E. (1992) Lys-plasminogen is a significant intermediate in the activation of Glu-plasminogen during fibrinolysis in vitro. J. Biol. Chem. 267, 26150-26156 (Pubitemid 23014029)
4. 78]plasminogen activation by native tissue-type plasminogen activator and variants that lack either the finger or kringle-2 domain. J. Biol. Chem. 272, 2183-2191
5. Hoylaerts, M., Rijken, D. C., Lijnen, H. R., and Collen, D. (1982) Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. J. Biol. Chem. 257, 2912-2919 (Pubitemid 12118804)
6. Bachmann, F. (2001) Hemostasis and Thrombosis, Lippincott Williams & Wilkins, Philadelphia, PA
7. Lijnen, H. R., Bachmann, F., Collen, D., Ellis, V., Pannekoek, H., Rijken, D. C., and Thorsen, S. (1994) Mechanisms of plasminogen activation. J. Intern. Med. 236, 415-424 (Pubitemid 24323203)
8. Collen, D., and Lijnen, H. R. (1991) Basic and clinical aspects of fibrinolysis and thrombolysis. Blood 78, 3114-3124
9. Sottrup-Jensen, L., Claeys, H., Zajdel, M., Petersen, T. E., and Magnusson, S. (1978) Progress in Chemical Fibrinolysis and Thrombolysis, Raven Press, New York, NY
10. Castellino, F. J., Ploplis, V. A., Powell, J. R., and Strickland, D. K. (1981) The existence of independent domain structures in human Lys77-plasminogen. J. Biol. Chem. 256, 4778-4782 (Pubitemid 11035333)
11. Straughn, W., 3rd, and Wagner, R. H. (1966) A simple method for preparing fibrinogen. Thromb. Diath. Haemorrh. 16, 198-206
12. Walker, J. B., and Nesheim, M. E. (1999) The molecular weights, mass distribution, chain composition, and structure of soluble fibrin degradation products released from a fibrin clot perfused with plasmin. J. Biol. Chem. 274, 5201-5212
13. Castellino, F. J., and Powell, J. R. (1981) Human plasminogen. Methods Enzymol. 80, 365-378
14. Stewart, R. J., Fredenburgh, J. C., and Weitz, J. I. (1998) Characterization of the interactions of plasminogen and tissue and vampire bat plasminogen activators with fibrinogen, fibrin, and the complex of D-dimer noncovalently linked to fragment E. J. Biol. Chem. 273, 18292-18299 (Pubitemid 28334753)
15. Nesheim, M., Fredenburgh, J. C., and Larsen, G. R. (1990) The dissociation constants and stoichiometries of the interactions of Lys-plasminogen and chloromethyl ketone derivatives of tissue plasminogen activator and the variant delta FEIX with intact fibrin. J. Biol. Chem. 265, 21541-21548 (Pubitemid 120014194)
16. Wu, H. L., Chang, B. I., Wu, D. H., Chang, L. C., Gong, C. C., Lou, K. L., and Shi, G. Y. (1990) Interaction of plasminogen and fibrin in plasminogen activation. J. Biol. Chem. 265, 19658-19664
17. Shi, G. Y., and Wu, H. L. (1988) Isolation and characterization of microplasminogen. A low molecular weight form of plasminogen. J. Biol. Chem. 263, 17071-17075
18. Fredenburgh, J. C., Stafford, A. R., Leslie, B. A., and Weitz, J. I. (2008) Bivalent binding to γA/γ′-fibrin engages both exosites of thrombin and protects it from inhibition by the antithrombin-heparin complex. J. Biol. Chem. 283, 2470-2477
19. Vu, T. T., Stafford, A. R., Leslie, B. A., Kim, P. Y., Fredenburgh, J. C., and Weitz, J. I. (2011) Histidine-rich glycoprotein binds fibrin(ogen) with high affinity and competes with thrombin for binding to the γ′- chain. J. Biol. Chem. 286, 30314-30323
20. Senis, Y. A., Kim, P. Y., Fuller, G. L., García, A., Prabhakar, S., Wilkinson, M. C., Brittan, H., Zitzmann, N., Wait, R., Warrell, D. A., Watson, S. P., Kamiguti, A. S., Theakston, R. D., Nesheim, M. E., and Laing, G. D. (2006) Isolation and characterization of cotiaractivase, a novel low molecular weight prothrombin activator from the venom of Bothrops cotiara. Biochim. Biophys. Acta 1764, 863-871
21. Schneider, M., and Nesheim, M. (2004) A study of the protection of plasmin from antiplasmin inhibition within an intact fibrin clot during the course of clot lysis. J. Biol. Chem. 279, 13333-13339 (Pubitemid 38468855)
22. Lucas, M. A., Fretto, L. J., and McKee, P. A. (1983) The binding of human plasminogen to fibrin and fibrinogen. J. Biol. Chem. 258, 4249-4256 (Pubitemid 13080643)
23. Motta, A., Laursen, R. A., Llinás, M., Tulinsky, A., and Park, C. H. (1987) Complete assignment of the aromatic proton magnetic resonance spectrum of the kringle 1 domain from human plasminogen. Structure of the ligand-binding site. Biochemistry 26, 3827-3836 (Pubitemid 17127454)
24. 1H NMR studies of aliphatic ligand binding to human plasminogen kringle 4. Biochemistry 28, 1368-1376
25. Lin, X., Takahashi, K., Campion, S. L., Liu, Y., Gustavsen, G. G., Peña, L. A., and Zamora, P. O. (2006) Synthetic peptide F2A4-K-NS mimics fibroblast growth factor-2 in vitro and is angiogenic in vivo. Int. J. Mol. Med. 17, 833-839
26. Suenson, E., and Thorsen, S. (1988) The course and prerequisites of Lys-plasminogen formation during fibrinolysis. Biochemistry 27, 2435-2443
27. Lamba, D., Bauer, M., Huber, R., Fischer, S., Rudolph, R., Kohnert, U., and Bode, W. (1996) The 2.3-Å crystal structure of the catalytic domain of recombinant two-chain human tissue-type plasminogen activator. J. Mol. Biol. 258, 117-135
28. Renatus, M., Bode, W., Huber, R., Stürzebecher, J., Prasa, D., Fischer, S., Kohnert, U., and Stubbs, M. T. (1997) Structural mapping of the active site specificity determinants of human tissue-type plasminogen activator. Implications for the design of low molecular weight substrates and inhibitors. J. Biol. Chem. 272, 21713-21719 (Pubitemid 27382784)
29. 1H NMR spectroscopy. J. Biol. Chem. 265, 3906-3915
30. Dobrovolsky, A. B., and Titaeva, E. V. (2002) The fibrinolysis system. Regulation of activity and physiologic functions of its main components. Biochemistry 67, 99-108
31. Komorowicz, E., Kolev, K., and Machovich, R. (1998) Fibrinolysis with des-kringle derivatives of plasmin and its modulation by plasma protease inhibitors. Biochemistry 37, 9112-9118 (Pubitemid 28299684)
32. Horrevoets, A. J., Smilde, A. E., Fredenburgh, J. C., Pannekoek, H., and Nesheim, M. E. (1995) The activation-resistant conformation of recombinant human plasminogen is stabilized by basic residues in the aminoterminal hinge region. J. Biol. Chem. 270, 15770-15776
33. Lijnen, H. R. (2001) Elements of the fibrinolytic system. Ann. N.Y. Acad. Sci. 936, 226-236